Muconasal Plus (Tramazoline Hydrochloride Monohydrate)

Tramazoline Hydrochloride, the active ingredient in Muconasal Plus, is a sympathomimetic amine presented as a nasal spray for nasal administration. It relieves nasal congestion associated with rhinitis and related upper‑respiratory conditions in adults and children. The formulation acts locally on the nasal mucosa to reduce swelling and improve airflow.

GNH USA supplies Muconasal Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across multiple regions through rigorous quality assurance processes.

Tramazoline Hydrochloride is a sympathomimetic nasal decongestant that reduces swelling of the nasal mucosa.

Nasal congestion: provides rapid relief of a blocked nose by constricting blood vessels in the nasal lining. Allergic rhinitis: diminishes swelling and improves breathing during allergy episodes. Common cold: alleviates nasal blockage associated with viral upper‑respiratory infections.

Tramazoline Hydrochloride may cause local and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning - Dryness of nasal passages - Transient headache

Serious or Rare Side Effects: - Elevated blood pressure or hypertension - Palpitations or tachycardia - Severe allergic reaction (anaphylaxis)

When using Muconasal Plus, observe the following precautions to ensure safe and effective treatment. - Duration of use: limit application to no more than three consecutive days to avoid rebound congestion. - Cardiovascular conditions: avoid in patients with uncontrolled hypertension or severe heart disease. - Thyroid disorders: use with caution in hyperthyroid patients. - Drug interactions: do not combine with other nasal decongestants or systemic sympathomimetics. - Pregnancy and lactation: consult a healthcare professional before use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Tramazoline Hydrochloride can interact with certain medicines; awareness of these interactions helps prevent adverse effects.

Major Interactions (Avoid): - MAO inhibitors: concurrent use may cause excessive sympathomimetic effects. - Other nasal decongestants (e.g., oxymetazoline, phenylephrine): risk of severe hypertension and rebound congestion.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (beta‑blockers, ACE inhibitors): may reduce blood‑pressure‑lowering effect. - Tricyclic antidepressants: potential additive cardiovascular stimulation. - Caffeine‑containing products: may increase mild stimulant effects.